Suit Says Zynex Directors' Deception Inflated Stock

Law360, New York (August 1, 2011, 2:32 PM EDT) -- Medical device manufacturer Zynex Inc. and its directors misled the public and shareholders by reporting increased revenues and product shipments, artificially inflating the company’s stock price, according to a shareholder derivative complaint filed Thursday in Colorado.

Investor Stephen Hatch lodged a complaint on behalf of the company, accusing Zynex’s senior officers of breaching their fiduciary duties by falsely certifying inaccurate earnings statements for the first three fiscal quarters of 2008. In reality, Zynex was only collecting a “small fraction” of the amounts reported, according to the...
To view the full article, register now.




Case Information

Case Title

Hatch v. Sandgaard et al

Case Number




Nature of Suit

Stockholders Suits


R. Brooke Jackson

Date Filed

July 28, 2011

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.